Real World Data (RWD) Market Report 2026

Real World Data (RWD) Market Overview

• Real World Data (RWD) market size has reached to $2.01 billion in 2025 • Expected to grow to $4.21 billion in 2030 at a compound annual growth rate (CAGR) of 15.8% • Growth Driver: The Increasing Adoption Of Electronic Health Records Driving The Growth Of The Market Due To Enhanced Patient Care And Safety • Market Trend: Innovative Healthcare Dataset Enhances Evidence Generation And Clinical Decisions • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Real World Data (RWD) Market?

Real-world data (RWD) refers to health-related data collected outside of traditional clinical trials from various sources such as electronic health records (EHRs), insurance claims, patient registries, wearable devices, and patient-reported outcomes. It reflects the routine delivery of healthcare and patient experiences in real-life settings. The primary purpose of RWD is to generate insights into how treatments perform in broader, more diverse populations under real-world conditions. It supports regulatory decisions, drug development, post-market surveillance, and personalized medicine by complementing data from controlled clinical trials. The main components of real-world data (RWD) are services and datasets. Services refer to professional solutions that support data collection, analysis, integration, or interpretation in healthcare and research, with real-world data services helping turn raw data into insights for decision-making and development. These data are applied across a range of applications, such as drug development and approvals, market access and reimbursement and coverage decisions, post-market surveillance, clinical research, and others, and serve a wide range of end users, including pharmaceutical and medical device companies, healthcare payers, healthcare providers, government agencies, and others.

What Is The Real World Data (RWD) Market Growth Forecast?

The real world data (rwd) market size is expected to see rapid growth in the next few years. It will grow to $4.21 billion in 2030 at a compound annual growth rate (CAGR) of 15.8%. The growth in the forecast period can be attributed to increasing regulatory acceptance of real-world evidence, rising focus on personalized medicine, expansion of AI-driven healthcare analytics, growing investments in digital health infrastructure, increasing use of rwd in value-based care models. Major trends in the forecast period include increasing adoption of real-world evidence in drug approvals, rising integration of multi-source healthcare datasets, growing use of wearable and patient-generated data, expansion of advanced data analytics platforms, enhanced focus on data standardization and interoperability.

Global Real World Data (RWD) Market Segmentation

1) By Component: Services, Datasets 2) By Application: Drug Development And Approvals, Market Access And Reimbursement And Coverage Decisions, Post-Market Surveillance, Clinical Research, Other Applications 3) By End User: Pharmaceutical And Medical Device Companies, Healthcare Payers, Healthcare Providers, Government Agencies, Other End Users Subsegments: 1) By Services: Data Collection Services, Data Integration And Management Services, Data Analytics And Visualization Services, Data Validation And Standardization Services, Regulatory Compliance And Consulting Services 2) By Datasets: Claims Data, Pharmacy Data, Electronic Health Records, Patient-Generated Health Data, Laboratory And Diagnostic Data, Genomic Data

What Is The Driver Of The Real World Data (RWD) Market?

The increasing adoption of electronic health records is expected to propel the growth of the real-world data (RWD) market going forward. Electronic health records refer to digital versions of patients’ medical charts that store and manage comprehensive health information to improve care coordination and decision-making. The increasing adoption of electronic health records is primarily due to the need to improve patient care and safety, as electronic health records enable accurate, real-time access to patient information, reduce medical errors, and enhance clinical decision-making. Real-world data enhances electronic health records by providing insights into patient outcomes and treatment effectiveness in everyday clinical settings, supporting more personalized and evidence-based care. For instance, in November 2023, according to NHS England, a UK-based government health authority, 90% of NHS hospital trusts had implemented an Electronic Patient Record (EPR) system, achieving the national adoption target ahead of schedule. Therefore, the increasing adoption of electronic health records is driving the growth of the real-world data market.

Key Players In The Global Real World Data (RWD) Market

Major companies operating in the real world data (rwd) market are Oracle Corporation, IQVIA Holdings Inc., ICON Public Limited Company, Syneos Health Inc., Parexel International Corporation, Revvity Inc., SAS Institute Inc., Datavant Inc., Palantir Technologies Inc., Tempus Labs Inc., Clarivate Plc, Flatiron Health Inc., Tempus Labs Inc., Clinigen Group plc, Komodo Health Inc., Aetion Inc., TriNetX LLC, Clarify Health Solutions Inc., Verana Health Inc., Evidation Health Inc., OM1 Inc., HealthVerity Inc., Pulse Infoframe Inc.

Global Real World Data (RWD) Market Trends and Insights

Major companies operating in the real-world data (RWD) market are focusing on introducing innovative solutions, such as integrated analysis-ready datasets, to streamline evidence generation and accelerate clinical decision-making. An integrated analysis-ready dataset refers to a cleaned, standardized, and combined set of data from multiple sources that is immediately usable for analysis without requiring additional preprocessing. For instance, in January 2025, Carelon Research, Inc., a US-based healthcare research company, launched Carelon Real World Data, a comprehensive, analysis-ready dataset designed to enhance healthcare evidence generation. This dataset offers a comprehensive, analysis-ready resource that integrates closed claims with electronic health records, capturing detailed information on patients, providers, and payers. It also includes enriched data on oncology, lab results, race and ethnicity, and social determinants of health. Built on decades of research, the dataset is tailored to meet specific research requirements and supports evidence generation across all therapeutic areas for life sciences teams.

What Are Latest Mergers And Acquisitions In The Real World Data (RWD) Market?

In December 2023, BC Platforms, a Finland-based company specialized in building data networks for the life sciences industry, acquired Medexprim for an undisclosed amount. With the acquisition, BC Platforms aims to expand its access to real-world data, particularly by integrating Medexprim’s expertise in clinical imaging, thereby enhancing their ability to provide comprehensive, multi-modal healthcare data solutions for research and innovation. MedPrime is a France-based software company that offers real-world data and real-world evidence.

Regional Insights

North America was the largest region in the real world data (RWD) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Real World Data (RWD) Market?

The real-world data (RWD) market includes revenues earned by entities by providing services, such as data collection services, data aggregation and integration, data analytics and insights, data licensing and subscription, and real-time monitoring services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Real World Data (RWD) Market Report 2026?

The real world data (rwd) market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the real world data (rwd) industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.